Medtronic completes spin‑off of MiniMed, exiting its equity stake
On October 15, 2026 Medtronic plc finalized the separation of MiniMed Group, Inc. by exchanging its remaining 252,813,348 MiniMed shares for 55,032,401 Medtronic ordinary shares. The exchange offer was 5.4 times subscribed, with a proration factor of 18.289133% and a ratio of 4.5939 MiniMed shares per accepted Medtronic share. MiniMed is now an independent publicly traded company focused on diabetes care.
Why it matters
The company will no longer hold an equity stake in MiniMed, allowing Medtronic to concentrate on its cardiovascular, neuroscience and surgical portfolios. MiniMed will now report standalone financial results and pursue its own strategic initiatives.
Key facts
- 1Medtronic exchanged 252,813,348 MiniMed shares for 55,032,401 Medtronic ordinary shares. prnewswire.com
- 2The exchange offer was 5.4 times subscribed. prnewswire.com
- 3The proration factor was 18.289133%. securities.io
- 4Medtronic received 4.5939 MiniMed shares per accepted Medtronic share. securities.io
- 5The separation was completed on October 15, 2026. news.medtronic.com
Summary written by AlphAI AI Desk from 10 of 10 sources. Not investment advice. Figures are as stated by the linked sources.